This interest developed over time into a passion that is fueled by his desire to help people in their darkest hours
FDA warns companies to stop selling injectable drug products containing growth hormone-releasing peptides
anthropometric measures (BMI)
Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British Womens Heart and Health Study and Meta-Analysis
To address the low water solubility and bioavailability, a platelet membrane (PM)-coated nanoparticle (NP) system was developed for targeted delivery of BBR (PM@Ber-NP) to inflammatory lungs of an house dust mite (HDM)-induced asthma mouse model [61]
Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity, JAMA Network Open (2022) Once-weekly semaglutide in adults with overweight or obesity, The New England Journal of Medicine (2021) Carnitine, National Institutes of Health (2023) Effects of three treatment modalities (diet, myoinositol, or myoinositol associated with D-chiro-inositol) on clinical and body composition outcomes in women with polycystic ovary syndrome, European Review for Medical and Pharmacological Sciences (2019) Who can perform semaglutide treatments?, American Med Spa Association (2023) Using fat-dissolving injections that are not FDA-approved can be harmful, U.S